Coronavirus Vaccine: 'Probably in new wear': India's drug controller hints at vaccine approval soon | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Friday
September 29, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
FRIDAY, SEPTEMBER 29, 2023
'Probably in new wear': India's drug controller hints at vaccine approval soon

Coronavirus chronicle

TBS Report
31 December, 2020, 04:10 pm
Last modified: 31 December, 2020, 05:27 pm

Related News

  • 'Indian' hackers take down Canada Army website amid soaring diplomatic tensions: Report
  • India imposes curfew in strife-hit areas of Manipur state
  • US, UK, Bangladesh leading source countries for India's foreign tourist arrivals in 2022
  • Ahead of Blinken-Jaishankar meet, US says stand on Canada row already made clear
  • Manipur govt declares entire state 'disturbed area' amid unrest

'Probably in new wear': India's drug controller hints at vaccine approval soon

Officials say the Oxford vaccine could be the first to get approval in India and be rolled out across the country

TBS Report
31 December, 2020, 04:10 pm
Last modified: 31 December, 2020, 05:27 pm
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo

The approval for a Covid-19 vaccine in India can come soon, the country's drugs control authority has indicated.

At a webinar on Thursday, India's Drugs Controller General Dr VG Somani said: "Probably we will have a happy New Year with something in hand. That is what I can hint at," reports the NDTV.

The assurance from the Drugs Controller General came ahead of a crucial meeting of the expert panel on emergency use vaccine authorization, which is set for Friday.

Earlier today, Prime Minister Narendra Modi said "Preparations are in last stages for the vaccination programme against Covid-19. People will get vaccine manufactured in India".

This week, the government-appointed panel has taken up applications for the emergency use approval of vaccines manufactured by the Serum Institute of India, Bharat Biotech and Pfizer.

Serum Institute is making 'Covishield' developed by Oxford University and Pharma major AstraZeneca. Bharat Biotech has partnered the Indian Council of Medical Research (ICMR) for its 'Covaxin'. Both firms have made presentations before the panel.

Pfizer has sought more time to present their data.

Once cleared by the expert panel, the applications will go to the drug controller for approval.

Officials say the Oxford vaccine could be the first to get approval in India and be rolled out across the country.

The Serum Institute, which is manufacturing the vaccine, has assured that a majority of the first 50 million doses will go to India.

"At least for the first month, most of our doses will go to India. We have a deal with other COVAX countries, but for exporting we will need approvals from World Health Organisation and licenses. So, India will receive first," company chief Adar Poonawalla has said.

Top News / World+Biz / South Asia

India / covid-19 vaccine / Oxford Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: RNPP project authorities.
    First shipment of nuclear fuel for Rooppur plant arrives in Dhaka 
  • Obaidul Quader speaking at the first meeting of AL's Election Manifesto Formulation Committee at the party's Bangabandhu Avenue central office this morning. Photo: BSS
    Bullet points in AL manifesto, people don't have time to read huge books: Quader 
  • Photo: ICC
    BCB President should give less interviews: Shakib

MOST VIEWED

  • Photo: Courtesy
    Shakib tears into Tamim, says refusal to bat in middle order 'childish'
  • Photo: Facebook
    Tamim's elder brother Nafees removed from team role on Shakib's request
  • Chief of Dhaka Metropolitan Police's Detective Branch Additional Commissioner Harun-Or-Rashid presents a sword to the newly appointed Chief Justice Obaidul Hassan at an event in the capital on Wednesday (27 September). Photo: Collected
    DB chief Harun presents sword to newly appointed chief justice
  • Court orders Jatiya Party vice chairman to repay Tk184 crore loan
    Court orders Jatiya Party vice chairman to repay Tk184 crore loan
  • Bangladesh slips in innovation index; lags behind India, Pakistan, Sri Lanka
    Bangladesh slips in innovation index; lags behind India, Pakistan, Sri Lanka
  • Govt allows trade unions in economic zones
    Govt allows trade unions in economic zones

Related News

  • 'Indian' hackers take down Canada Army website amid soaring diplomatic tensions: Report
  • India imposes curfew in strife-hit areas of Manipur state
  • US, UK, Bangladesh leading source countries for India's foreign tourist arrivals in 2022
  • Ahead of Blinken-Jaishankar meet, US says stand on Canada row already made clear
  • Manipur govt declares entire state 'disturbed area' amid unrest

Features

More than 86 lakh Bangladeshis went abroad as migrant workers in the last 14 years, according to BMET (Bureau of Manpower, Employment and Training). Naturally, these workers return to Bangladesh at some point to settle down. Photo: Syed Zakir Hossain

Why migrant workers have a hard time back at home

1d | Panorama
What impact will a forward forex rate have?

What impact will a forward forex rate have?

1d | Panorama
India-Canada clash should be a wakeup call

India-Canada clash should be a wakeup call

2d | Panorama
It is highly unlikely that inflation rate is going to come down soon. PHOTO: TBS

No more central bank loans to the govt: Will it be enough to curb inflation?

2d | Panorama

More Videos from TBS

Unarmed Armenians do not want to return to Nagorno-Karabakh

Unarmed Armenians do not want to return to Nagorno-Karabakh

1d | TBS World
Is injury the main reason Tamim is excluded from WC Squad?

Is injury the main reason Tamim is excluded from WC Squad?

1d | TBS SPORTS
Tourism master plan aims to attract 5.57m tourists annually by 2041

Tourism master plan aims to attract 5.57m tourists annually by 2041

16h | TBS Today
Best Missing XI: ODI World Cup 2023

Best Missing XI: ODI World Cup 2023

6h | TBS SPORTS
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]